Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LabTurbo BiotechROCO:7725 36 5-Year Yield-on-Cost % is 0.86 as of Aug. 21, 2026, which is 57% below its 10-year median of 1.98. GuruFocus rates ROCO:7725 with a GF Score™ of 36/100 and a GF Value™ of NT$28.28 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 150 Biotechnology companies, LabTurbo Biotech ranks worse than 68.67% on this metric.
LabTurbo Biotech's yield on cost for the quarter that ended in Jun. 2026 was 0.86.
The historical rank and industry rank for LabTurbo Biotech's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:7725'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.86 Med: 1.98 Max: 2.53
Current: 0.86
During the past 5 years, LabTurbo Biotech's highest Yield on Cost was 2.53. The lowest was 0.86. And the median was 1.98.
ROCO:7725's 5-Year Yield-on-Cost % is ranked worse than 68.67% of 150
companies
in the Biotechnology industry
Industry Median: 1.655
vs ROCO:7725: 0.86
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
LabTurbo Biotech 5-Year Yield-on-Cost % Related Terms
ROCO:7725 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, LabTurbo Biotech's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LabTurbo Biotech 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LabTurbo Biotech's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where LabTurbo Biotech's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
LabTurbo Biotech (ROCO:7725) has a 5-Year Yield-on-Cost % of 0.86 as of Aug. 21, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on LabTurbo Biotech and its competitors. This is 57% below median its historical median of 1.98. Over the past decade, LabTurbo Biotech's 5-Year Yield-on-Cost % has ranged from 0.86 to 2.53. According to the industry distribution chart, LabTurbo Biotech ranks #103 out of 150 companies in the Biotechnology industry, placing it in the top 68.7%.
Is LabTurbo Biotech's 5-Year Yield-on-Cost % too high?
LabTurbo Biotech's current 5-Year Yield-on-Cost % of 0.86 is 57% below median its 10-year median of 1.98. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 2.53. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.66. LabTurbo Biotech's value of 0.86 is 48% below this industry median. Based on the distribution chart, LabTurbo Biotech ranks #103 out of 150 companies in the Biotechnology industry, which is below the industry midpoint. Overall, LabTurbo Biotech has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LabTurbo Biotech's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, LabTurbo Biotech ranks #103 out of 150 companies for 5-Year Yield-on-Cost %. This places LabTurbo Biotech in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.66. LabTurbo Biotech's value of 0.86 is 48% below this benchmark. Historically, LabTurbo Biotech's own 5-Year Yield-on-Cost % has ranged from 0.86 to 2.53 over the past decade. While the company's 10-year median is 1.98 vs. the industry median of 1.66, LabTurbo Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.66, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LabTurbo Biotech's current 5-Year Yield-on-Cost % of 0.86 is 48% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on LabTurbo Biotech and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LabTurbo Biotech's current 5-Year Yield-on-Cost % is 0.86, which is 57% below median its own 10-year median of 1.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LabTurbo Biotech stock overvalued right now?
Based on GuruFocus' analysis, LabTurbo Biotech (ROCO:7725) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$28.28, compared to a current price of NT$23.15 — trading 18.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.86, which is 57% below median its 10-year median of 1.98 and 48% below the Biotechnology industry median of 1.66. LabTurbo Biotech's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For LabTurbo Biotech (ROCO:7725), the current 5-Year Yield-on-Cost % is 0.86 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LabTurbo Biotech (ROCO:7725) Overvalued in 2026?
Based on GuruFocus' analysis, LabTurbo Biotech stock appears to be undervalued.
The current stock price of NT$23.15 is trading 18.1% below its estimated GF Value™ of NT$28.28.
GuruFocus considers LabTurbo Biotech to be Modestly Undervalued.
Key valuation signals for ROCO:7725:
5-Year Yield-on-Cost %: 0.86 (57% below median its 10-year median of 1.98)
GF Value™: NT$28.28 vs. price of NT$23.15 (18.1% below fair value)
Industry Position: 48% below the Biotechnology median (#103 of 150)
No single metric tells the full story. See the ROCO:7725 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
36GF Score
Get the complete analysis for ROCO:7725
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7725 has been successfully added to your 
